Clinical trial shows rheumatoid arthritis drug could prevent disease

A drug used to treat rheumatoid arthritis could also prevent the disease in individuals deemed to be at risk.

Results from a Phase 2b clinical trial, published in The Lancet by researchers led by King's College London, provides hope for arthritis sufferers after it was shown that the biologic drug abatacept reduces progression to this agonising chronic inflammatory disease.

from Breaking World Pharma News https://ift.tt/mXU8KHA